title: Non-Hodgkin lymphoma response evaluation with MRI texture classification.
abstract: BACKGROUND
  To show magnetic resonance imaging (MRI) texture appearance change in non-Hodgkin lymphoma (NHL) during treatment with response controlled by quantitative volume analysis.
  
  
  METHODS
  A total of 19 patients having NHL with an evaluable lymphoma lesion were scanned at three imaging timepoints with 1.5T device during clinical treatment evaluation. Texture characteristics of images were analyzed and classified with MaZda application and statistical tests.
  
  
  RESULTS
  NHL tissue MRI texture imaged before treatment and under chemotherapy was classified within several subgroups, showing best discrimination with 96% correct classification in non-linear discriminant analysis of T2-weighted images.Texture parameters of MRI data were successfully tested with statistical tests to assess the impact of the separability of the parameters in evaluating chemotherapy response in lymphoma tissue.
  
  
  CONCLUSIONS
  Texture characteristics of MRI data were classified successfully; this proved texture analysis to be potential quantitative means of representing lymphoma tissue changes during chemotherapy response monitoring.
authors: Tampere University Medical School, Tampere, Finland. lara.harrison@tut.fi
authors: Lara C V
authors: LC
authors: Harrison
authors: Tiina
authors: T
authors: Luukkaala
authors: Hannu
authors: H
authors: Pertovaara
authors: Tuomas O
authors: TO
authors: Saarinen
authors: Tomi T
authors: TT
authors: Heinonen
authors: Ritva
authors: R
authors: Järvenpää
authors: Seppo
authors: S
authors: Soimakallio
authors: Pirkko-Liisa I
authors: PL
authors: Kellokumpu-Lehtinen
authors: Hannu J
authors: HJ
authors: Eskola
authors: Prasun
authors: P
authors: Dastidar
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents